Literature DB >> 35261679

Pregnancy and Delivery in a 27-Year-Old ICD Carrier.

Oana Muscalu1, Dragos Tudorache2, Bianca-Margareta Mihai3, Ioana Teodora Vladareanu4, Roxana Elena Bohiltea5.   

Abstract

Implantable cardiac devices represent the first line treatment option used not only for secondary prevention of sudden cardiac death but also for primary prevention in patients with cardiac pathologies considered at risk of sudden cardiac death caused by ventricular tachycardia or ventricular fibrillation. The number of women with implantable cardiac devices reaching child bearing age is expected to increase more and more in the next years. Despite this tendency, there are only a few reported cases of pregnancies in implantable cardiac defibrillator carriers, leading to insufficient evidence and clear guideline recommendations on how to manage and monitor pregnancy in patients with this type of cardiac pathology. Closely monitoring within a multidisciplinary team consisting of an obstretician, electrophysiologist and anesthesiologist is required for this group of pregnant patients in order to achieve the best maternal and neonatal results. The present study describes the case of succesful outcome in a 27-year-old implantable cardiac defibrillator carrier implanted after an aborted cardiac arrest and reccurent polymorphic ventricular tachycardia due to myocarditis eight years prior to pregnancy, with an aim to emphasize the monitoring particularities and management during pregnancy.

Entities:  

Year:  2021        PMID: 35261679      PMCID: PMC8897792          DOI: 10.26574/maedica.2020.16.4.729

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  11 in total

Review 1.  Perioperative management of patients with cardiac implantable electronic devices.

Authors:  M E Stone; B Salter; A Fischer
Journal:  Br J Anaesth       Date:  2011-12       Impact factor: 9.166

2.  β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.

Authors:  Lewei Duan; Angie Ng; Wansu Chen; Hillard T Spencer; Jennifer Nguyen; Albert Y-J Shen; Ming-Sum Lee
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

3.  β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study.

Authors:  Brian T Bateman; Uffe Heide-Jørgensen; Kristjana Einarsdóttir; Anders Engeland; Kari Furu; Mika Gissler; Sonia Hernandez-Diaz; Helle Kieler; Anna-Maria Lahesmaa-Korpinen; Helen Mogun; Mette Nørgaard; Johan Reutfors; Randi Selmer; Krista F Huybrechts; Helga Zoega
Journal:  Ann Intern Med       Date:  2018-10-16       Impact factor: 25.391

4.  Long-Term Arrhythmic Risk Assessment in Biopsy-Proven Myocarditis.

Authors:  Gemma Pelargonio; Gaetano Pinnacchio; Maria Lucia Narducci; Maurizio Pieroni; Francesco Perna; Gianluigi Bencardino; Gianluca Comerci; Antonio Dello Russo; Michela Casella; Stefano Bartoletti; Eleonora Russo; Filippo Crea
Journal:  JACC Clin Electrophysiol       Date:  2020-02-26

5.  Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

Authors:  Thomas Kleemann; Torsten Becker; Klaus Doenges; Margit Vater; Jochen Senges; Steffen Schneider; Werner Saggau; Udo Weisse; Karlheinz Seidl
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

6.  Pregnancy in women with an implantable cardioverter-defibrillator: is it safe?

Authors:  Stéphane Boulé; Lionel Ovart; Christelle Marquié; Edward Botcherby; Didier Klug; Claude Kouakam; François Brigadeau; Laurence Guédon-Moreau; Ludivine Wissocque; Jonathan Meurice; Dominique Lacroix; Salem Kacet
Journal:  Europace       Date:  2014-03-03       Impact factor: 5.214

7.  Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.

Authors:  Ebru Ertekin; Iris M van Hagen; Amar M Salam; Titia P E Ruys; Mark R Johnson; Jana Popelova; William A Parsonage; Zeinab Ashour; Avraham Shotan; José M Oliver; Gruschen R Veldtman; Roger Hall; Jolien W Roos-Hesselink
Journal:  Int J Cardiol       Date:  2016-06-23       Impact factor: 4.164

8.  Beta-blocker subtypes and risk of low birth weight in newborns.

Authors:  Lewei Duan; Angie Ng; Wansu Chen; Hillard T Spencer; Ming-Sum Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-28       Impact factor: 3.738

9.  2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Authors:  Vera Regitz-Zagrosek; Jolien W Roos-Hesselink; Johann Bauersachs; Carina Blomström-Lundqvist; Renata Cífková; Michele De Bonis; Bernard Iung; Mark Richard Johnson; Ulrich Kintscher; Peter Kranke; Irene Marthe Lang; Joao Morais; Petronella G Pieper; Patrizia Presbitero; Susanna Price; Giuseppe M C Rosano; Ute Seeland; Tommaso Simoncini; Lorna Swan; Carole A Warnes
Journal:  Eur Heart J       Date:  2018-09-07       Impact factor: 29.983

Review 10.  Management of Implantable Cardioverter-Defibrillators during Pregnancy-A Systematic Review.

Authors:  Albert Topf; Nina Bacher; Kristen Kopp; Moritz Mirna; Robert Larbig; Mathias C Brandt; Johannes Kraus; Uta C Hoppe; Lukas J Motloch; Michael Lichtenauer
Journal:  J Clin Med       Date:  2021-04-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.